An immunohistochemical study of the mesenchymal and epithelial components of pulmonary chondromatous hamartomas

Pathology International

Volumn 49, Issue 11, 1999, Pages 938-946

  Takemura, Tamiko ^a   Kusafuka, Kimihide ^a   Fujiwara, Mutsunori ^a   Masuda, Ryo ^a   Furuhata, Yoshiaki ^a   Tanaka, Isao ^a   Inoue, Masaharu ^a  

^a JAPANESE RED CROSS MEDICAL CENTER   (Japan)

Author keywords

Epithelial component; Immunohistochemistry; Mesenchymal component; Pulmonary chondromatous hamartoma

Indexed keywords

COLLAGEN; CYCLINE; FIBROBLAST GROWTH FACTOR; FIBRONECTIN; PROTEIN S 100;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIUM; FEMALE; HAMARTOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG TUMOR; MALE; MESENCHYME; PRIORITY JOURNAL; THORAX RADIOGRAPHY;

ADULT; AGED; ANTIGENS, CD34; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; EPITHELIAL CELLS; EXTRACELLULAR MATRIX PROTEINS; FEMALE; FIBROBLAST GROWTH FACTOR 2; HAMARTOMA; HUMANS; IMMUNOENZYME TECHNIQUES; LUNG DISEASES; MALE; MESODERM; MIDDLE AGED; PHENOTYPE; S100 PROTEINS;

EID: 0033427955     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1827.1999.00969.x     Document Type: Article

References (30)

1. 1 Bateson EM. Relationship between intrapulmonary and endobronchial cartilage-containing tumours (so-called hamartomata) Thorax 1965; 20: 447-461.
2. 2 Bateson EM. So-called hamartoma of the lung-A true neoplasm of fibrous connective tissue of the bronchi. Cancer 1973; 31: 1458-1467.
3. 3 Van den Bosch JM, Wagenaar SS, Corrin B, Elbers JRJ, Knaepen PJ, Westermann CJJ. Mesenchymoma of the lung (so called hamartoma): A review of 154 parenchymal and endobronchial cases. Thorax 1987; 42: 790-793.
4. 4 Incze JS, Lui PS. Morphology of the epithelial component of human lung hamartomas. Hum. Pathol. 1977; 8: 411-419.
5. 5 Stone FJ, Churg AM. The ultrastructure of pulmonary hamartoma. Cancer 1977; 39: 1064-1070.
6. 6 Perez-Atayde AR, Seiler MW. Pulmonary hamartoma. An ultrastructural study. Cancer 1984; 53: 485-492.
7. 7 Fletcher JA, Pinkus GS, Donovan K et al. Clonal rearrangement of chromosome band 6p21 in the mesenchymal component of pulmonary chondroid hamartoma. Cancer Res. 1992; 52: 6224-6228.
8. 8 Xiao S, Lux ML, Reeves R, Hudson TJ, Fletcher JA. HMGI (Y) activation by chromosome, 6p21 rearrangements in multilineage mesenchymal cells from pulmonary hamartoma. Am. J. Pathol. 1997; 150: 901-910.
9. 9 Dal Cin P, Kools P, De Jonge I, Moerman P, Van de Ven W, Van den Berghe H. Rearrangement of 12q14-15 in pulmonary chondroid hamartoma. Genes Chromosom. Cancer 1993; 8: 131-133.
10. 10 Fletcher JA, Longtine J, Wallace K, Mentzer SJ, Sugarbaker DJ. Cytogenetic and histologic findings in 17 pulmonary chondroid hamartomas: Evidence for a pathogenetic relationship with lipomas and leiomyomas. Genes Chromosom. Cancer 1995; 12: 220-223.
11. 11 Kazmierczak B, Rosigkeit J, Wanschura S et al. HMGI-C rearrangements as the molecular basis for the majority of pulmonary chondroid hamartomas. A survey of 30 tumors. Oncogene 1996; 12: 515-521.
12. 12 Fletcher JA, Pinkus GS, Weidner N, Motion CC. Lineage-restricted clonality in biphasic solid tumors. Am. J. Pathol. 1991; 138: 1199-1207.
13. 13 Wiatrowska BA, Yazdi HM, Matzinger FRK, MacDonald LL. Fine needle aspiration of pulmonary hamartomas. Radiographic, cytologic and immunocytochemical study of 15 cases. Acta Cytol. 1995; 39: 1167-1174.
14. 14 Stefansson K, Wollmman RL, Moore BW, Amason BGW. S-100 protein in human chondrocytes. Nature 1982; 295: 63-64.
15. 15 Crocker J, Jenkins R, Campbell J, Fuggele WJ, Shah VM. Immunohistochemical demonstration of S-100 protein in salivary gland neoplasms. J. Pathol. 1985; 146: 115-121.
16. 16 Hanau CA, Miettinen M. Solitary fibrous tumor: Histological and immunohistochemical spectrum of benign and malignant variants presenting at different sites. Hum. Pathol. 1995; 26: 440-449.
17. 17 Kuhn III CE, Boldt J, King TE Jr, Crouch E, Vartio T, McDonald JA. An immunohistochemical study of architectural remodelling and connective tissue synthesis in pulmonary fibrosis. Am. Rev. Respir. Dis. 1989; 140: 1693-1703.
18. 18 Kuhn C, McDonald JA. The roles of the myofibroblast in idiopathic pulmonary fibrosis. Ultrastructural and immunohistochemical features of sites of active extracellular matrix synthesis. Am. J. Pathol. 1991; 138: 1257-1265.
19. 19 Kato Y, Iwamoto M. Fibroblast growth factor is an inhibitor of chondrocyte terminal differentiation. J. Biol. Chem. 1990; 265: 5903-5909.
20. 20 Schulze-Ostoff K, Risau W, Vollmer E, Sorg C. In situ detection of basic fibroblast growth factor by highly specific antibodies. Am. J. Pathol. 1990; 137: 85-92.
21. 21 Kusafuka K, Yamaguchi A, Kayano T, Takemura T. Immunohistochemical localization of fibroblast growth factors (FGFs) and FGF-receptor 1 in human normal salivary glands and pleomorphic adenomas. J. Oral Pathol. Med. 1998; 27: 287-292.
22. 22 Hiraki Y, Inoue H, Iyama K et al. Identification of chondromodulin I as a novel endothelial cell growth inhibitor. Purification and its localization in the avascular zone of epiphyseal cartilage. J. Biol. Chem. 1997; 272: 32 419-32 426.
23. 23 Valdes-Dapena MA. Histology of the Fetus and Newborn. WB Saunders, Philadelphia, 1979.
24. 24 Hirai Y, Takabe K, Takashina M, Kobayashi S, Takeichi M. Epimorphin: A mesenchymal protein essential for epithelial morphogenesis. Cell 1992; 69: 471-481.
25. 25 Nilbert M, Heim S. Uterine leiomyoma cytogenetics. Genes Chromosom. Cancer 1990; 2: 3-13.
26. 26 Mandahl N, Hoglund M, Mertens F et al. Cytogenetic aberrations in 188 benign and borderline adipose tumours. Genes Chromosom. Cancer 1994; 9: 207-215.
27. 27 Kools P, Wanschura S, Schoenmakers E et al. Identification of the chromosome 12 translocation breakpoint region of a pleomorphic salivary gland adenoma with t(1;12) (p22;q15) as the sole cytogenetic abnormality. Cancer Genet. Cytogenet. 1995; 79: 1-7.
28. 28 Vanni R, Dal Cin O, Marras S et al. Endometrial polyp: Another benign tumor characterized by 12q13-q15 changes. Cancer Genet. Cytogenet. 1993; 68: 32-33.
29. 29 Tallini G, Dal Cin P, Rhoden KJ et al. Expression of HMGI-C and HMGI (Y) in ordinary lipoma and atypical lipomatous tumors. Immunohistochemical reactivity correlates with karyotypic alterations. Am. J. Pathol. 1997; 151: 37-43.
30. 30 Williams AJ, Powell WL, Collins T, Morton CC. HMGI (Y) expression in human uterine leiomyomata. Involvement of another high-mobility group architectural factor in a benign neoplasm. Am. J. Pathol. 1997; 150: 911-918.